Knowing the kind of receptor on the cell for which the medicine will be targeted and using cell-specific ligands will enable the nanoparticle to attach exclusively to the cell that has the corresponding receptor. Cellular targeting is one method to actively target just sick tissue in the body. Intracellular delivery, a long-researched area in contemporary biotechnology, allows for effective medication administration into a variety of cell types. It is a crucial step in several cellular-level investigations, including gene delivery for gene editing and a number of biological research applications.
a. Targeted Drug Delivery System: A targeted drug delivery system is a specialised type of medication administration in which the drug is only delivered at the site of action and not to the target organs, tissues, or cells.
b. Drug Targeting and Design: The capacity of a drug to acquire in the target tissue or organ particularly, so that the concentration of drug will be high at the illness, while its concentration is low in non-target organs and tissues, preferably below the certain minimal level to prevent any toxic effects, is referred to as drug targeting.
The non-specific harmful impact of traditional medication administration can be reduced using drug targeting. Another name for drug design is rational drug design or just rational design.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia